Outputs (17)

Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial (2024)
Journal Article
Cornelius, V., Babalis, D., Carroll, W. D., Cunningham, S., Fleming, L., Gaillard, E., …Saglani, S. (2024). Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial. BMJ Open, 14(8), https://doi.org/10.1136/bmjopen-2024-090749

Introduction: A minority of school-aged children with asthma have persistent poor control and experience frequent asthma attacks despite maximal prescribed maintenance therapy. These children have higher morbidity and risk of death. The first add-on... Read More about Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial.

Antibiotics for relapses of protracted bacterial bronchitis (2024)
Journal Article
Stock, J., Carroll, W., & Gilchrist, F. J. (in press). Antibiotics for relapses of protracted bacterial bronchitis. Cochrane Database of Systematic Reviews, 2024(4), https://doi.org/10.1002/14651858.cd015648

P46 How and when do patients dispose of old or unwanted inhalers? (2023)
Presentation / Conference
Murphy, A., Carroll, W., Gotsell, M., Potter, C., Quint, J., & Malone, R. (2023, November). P46 How and when do patients dispose of old or unwanted inhalers?. Poster presented at British Thoracic Society Winter Meeting 2023, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, England

COVID‐19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis (2022)
Journal Article
Driscoll, S., Carroll, W. D., Nichani, S., Gilchrist, F. J., Fishwick, R., & Bakewell, K. (2022). COVID‐19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis. Pediatric Pulmonology, 57(7), 1823-1825. https://doi.org/10.1002/ppul.25954

Letter

Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis (2021)
Journal Article
Carroll, W., Green, J., & Gilchrist, F. J. (in press). Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. Cochrane Database of Systematic Reviews, 2021(12), https://doi.org/10.1002/14651858.cd012619.pub3

Background
Cystic fibrosis (CF) is the most common, life‐limiting, genetically inherited disease. It affects multiple organs, particularly the respiratory system. However, gastrointestinal problems such as constipation and distal intestinal obstruct... Read More about Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis (2021)
Journal Article
Gilchrist, F. J., Green, J., & Carroll, W. (2021). Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. Cochrane Database of Systematic Reviews, https://doi.org/10.1002/14651858.CD012798.pub3

BACKGROUND: Cystic fibrosis is the most common life-limiting autosomal recessive genetic disorder in white populations. Distal intestinal obstruction syndrome (DIOS) is an important morbidity in cystic fibrosis. It is the result of the accumulation o... Read More about Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Chapter 17: Respiratory Disorders (2021)
Book Chapter
Gilchrist, F., & Carroll, W. (2021). Chapter 17: Respiratory Disorders. In Illustrated Textbook of Paediatrics, 6th Edition. Elsevier

The ERS approach to e-cigarettes is entirely rational (2020)
Journal Article
Bush, A., Bhatt, J. M., Carroll, W., Child, F., Connett, G., Doull, I., …Sinha, I. (2020). The ERS approach to e-cigarettes is entirely rational. European Respiratory Journal, 55(5), Article ARTN 2000413. https://doi.org/10.1183/13993003.00413-2020

'No abstract'

Duration of initial antibiotic course is associated with recurrent relapse in protracted bacterial bronchitis (2019)
Journal Article
Gross-Hodge, E., Carroll, W. D., Rainford, N., Gamble, C., & Gilchrist, F. J. (2020). Duration of initial antibiotic course is associated with recurrent relapse in protracted bacterial bronchitis. Archives of Disease in Childhood, 105(11), 1111-1113. https://doi.org/10.1136/archdischild-2019-317917

Duration of initial antibiotic course is associated with recurrent relapse in protracted bacterial bronchitis (2019)
Presentation / Conference
Grose-Hodge, E., Carroll, W., Rainford, N., Gamble, C., & Gilchrist, F. (2019, September). Duration of initial antibiotic course is associated with recurrent relapse in protracted bacterial bronchitis. Presented at ERS International Congress 2019, Madrid, Spain

Background: Protracted Bacterial Bronchitis (PBB) is a leading cause of chronic wet cough in children. Antibiotic response is a diagnostic criterion but there is little evidence to inform duration of treatment. Relapse is common and those who relapse... Read More about Duration of initial antibiotic course is associated with recurrent relapse in protracted bacterial bronchitis.